DE60041839D1 - Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs - Google Patents

Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs

Info

Publication number
DE60041839D1
DE60041839D1 DE60041839T DE60041839T DE60041839D1 DE 60041839 D1 DE60041839 D1 DE 60041839D1 DE 60041839 T DE60041839 T DE 60041839T DE 60041839 T DE60041839 T DE 60041839T DE 60041839 D1 DE60041839 D1 DE 60041839D1
Authority
DE
Germany
Prior art keywords
auto
marker
lung cancer
antibodies against
annexin proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041839T
Other languages
English (en)
Inventor
Samir M Hanash
David Misek
Robert Hinderer
David Beer
Franck Brichory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Application granted granted Critical
Publication of DE60041839D1 publication Critical patent/DE60041839D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4718Lipocortins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60041839T 1999-08-06 2000-08-04 Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs Expired - Lifetime DE60041839D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/370,337 US6645465B2 (en) 1999-08-06 1999-08-06 Annexin proteins and autoantibodies as serum markers for cancer

Publications (1)

Publication Number Publication Date
DE60041839D1 true DE60041839D1 (de) 2009-04-30

Family

ID=23459219

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60041839T Expired - Lifetime DE60041839D1 (de) 1999-08-06 2000-08-04 Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
DE60028040T Expired - Lifetime DE60028040T2 (de) 1999-08-06 2000-08-04 Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60028040T Expired - Lifetime DE60028040T2 (de) 1999-08-06 2000-08-04 Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs

Country Status (10)

Country Link
US (5) US6645465B2 (de)
EP (3) EP1734368B1 (de)
JP (1) JP4594575B2 (de)
AT (3) ATE529751T1 (de)
AU (1) AU780772B2 (de)
CA (1) CA2380398C (de)
DE (2) DE60041839D1 (de)
DK (2) DK1734368T3 (de)
ES (2) ES2320585T3 (de)
WO (1) WO2001011372A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US6869934B2 (en) * 2000-07-21 2005-03-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method of purifying calcium ion-binding protein
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
EP1379266B1 (de) 2001-02-21 2007-04-18 SurroMed, Inc. Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
EP1428028A2 (de) * 2001-09-14 2004-06-16 Reinhard Zeidler Identifizierung von antigenen durch xenogene, allogene oder autologe antikörper-vermittelte präzipitation
US20050221305A1 (en) * 2001-11-09 2005-10-06 Benaroya Research Institute At Virginia Mason Antigen panels and methods of using the same
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
EP1601969A2 (de) 2003-03-08 2005-12-07 Auvation Ltd Marker für dickdarmkrebs
CA2555866A1 (en) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostic markers for cancer
EP1756572B1 (de) * 2004-05-13 2016-02-24 Centre National De La Recherche Scientifique (Cnrs) Vorrichtung zur bindung eines zielelements an ein köderelement sowie nachweisverfahren damit
US7943294B2 (en) * 2004-07-30 2011-05-17 Hologic, Inc. Methods for detecting oncofetal fibronectin
RU2277242C2 (ru) * 2004-08-23 2006-05-27 Александр Владимирович Балюра Способ диагностики опухолей
JP4521575B2 (ja) * 2005-03-17 2010-08-11 国立大学法人 千葉大学 特発性肺線維症の検出マーカー、検出キット及び検出方法
EP1724585A1 (de) * 2005-05-21 2006-11-22 ProteoSys AG Annexin für Krebsrisikofeststellung
EP1724586A3 (de) * 2005-05-21 2007-07-04 ProteoSys AG Annexin für Krebsrisikomanagement
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
JP5405111B2 (ja) * 2005-09-26 2014-02-05 ウルリヒ ルース Tsh受容体及び新規tsh受容体キメラに対する自己免疫抗体検出方法
BRPI0619712A2 (pt) * 2005-11-10 2011-10-11 Univ Kentucky dispositivo para a identificação de um paciente como um candidato para testes radiográficos para o cáncer do pulmão, composição para detectar radiograficamente um cáncer do pulmão de estágio adiantado, dispositivo para o ensaio do cáncer do pulmão, uso de um painel, e, dispositivo de diagnóstico para a detecção do cáncer do pulmão
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CN101490550A (zh) * 2006-07-08 2009-07-22 肯塔基大学研究基金会 肺癌诊断分析
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
MX2009004460A (es) * 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20090047689A1 (en) * 2007-06-20 2009-02-19 John Kolman Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
JP2012500964A (ja) * 2008-05-09 2012-01-12 デューク ユニバーシティ 癌の検出と治療における自己抗体
US9581599B2 (en) 2010-06-28 2017-02-28 The Board Of Regents Of The University Of Texas System Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2
WO2012048190A1 (en) * 2010-10-08 2012-04-12 Regents Of The University Of Minnesota Annexin ii compositions and methods
KR20150010882A (ko) * 2013-07-19 2015-01-29 삼성전자주식회사 아넥신 A2 결합단백질, p53 단백질 및 p18 단백질을 포함하는 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 조성물
US20160291025A1 (en) * 2013-09-18 2016-10-06 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer
CA2930567C (en) 2013-11-13 2023-09-26 Regents Of The University Of Minnesota Annexin ii variant compositions and methods
CN104407151B (zh) * 2014-11-19 2016-06-08 汕头大学医学院 Kindlin-2,Myosin-9和Annexin II三蛋白联合预测食管鳞癌患者预后试剂盒
CN113721021B (zh) * 2021-09-16 2023-07-07 郑州大学 Prkcz自身抗体在食管鳞癌辅助诊断中的应用
CN116539885B (zh) * 2023-07-06 2023-09-29 上海秤信生物科技有限公司 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02496A (ja) * 1987-12-24 1990-01-05 Nippon Shinyaku Co Ltd モノクローナル抗体、製法、及び利用法
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
DE4040306A1 (de) 1990-12-17 1992-06-25 Behringwerke Ag Verfahren zur bestimmung von antikoerpern gegen lipocortine
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
JPH0772149A (ja) * 1993-06-30 1995-03-17 Nippon Shinyaku Co Ltd 肝癌又は肝硬変の診断薬及び診断法
JPH0772147A (ja) * 1993-07-02 1995-03-17 Noboru Kaneko 抗アネキシンv抗体並びに該抗体の製法及び利用
EP0651253A1 (de) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay zum Nachweis menschlicher Autoantikörper
US5658877A (en) * 1995-05-18 1997-08-19 Wisconsin Alumni Research Foundation Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein
AU8267398A (en) 1997-06-26 1999-01-19 Regents Of The University Of Michigan, The Method for identification of tumor antigens with autoantibodies in serum
CA2274776C (en) * 1997-10-08 2008-11-25 Noboru Kaneko Method for analyzing annexin v in urine and use thereof
AU762512B2 (en) * 1998-12-28 2003-06-26 Atossa Genetics, Inc. Devices, methods and systems for collecting material from a breast duct
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer

Also Published As

Publication number Publication date
WO2001011372A9 (en) 2002-04-11
US20070037227A1 (en) 2007-02-15
ATE426167T1 (de) 2009-04-15
DE60028040T2 (de) 2006-11-23
US20060275845A1 (en) 2006-12-07
WO2001011372A1 (en) 2001-02-15
US7955602B2 (en) 2011-06-07
EP1734368A3 (de) 2007-03-07
US6645465B2 (en) 2003-11-11
EP1734368A2 (de) 2006-12-20
ES2259609T3 (es) 2006-10-16
EP2051079A2 (de) 2009-04-22
EP1734368B1 (de) 2009-03-18
ATE326699T1 (de) 2006-06-15
ATE529751T1 (de) 2011-11-15
AU6526200A (en) 2001-03-05
US20040048320A1 (en) 2004-03-11
CA2380398A1 (en) 2001-02-15
US20100330587A1 (en) 2010-12-30
EP2051079A3 (de) 2009-06-10
AU780772B2 (en) 2005-04-14
CA2380398C (en) 2017-01-31
US7759081B2 (en) 2010-07-20
DK1200832T3 (da) 2006-09-18
JP4594575B2 (ja) 2010-12-08
EP1200832B1 (de) 2006-05-17
EP2051079B1 (de) 2011-10-19
EP1200832A1 (de) 2002-05-02
ES2320585T3 (es) 2009-05-25
DK1734368T3 (da) 2009-06-02
JP2003535309A (ja) 2003-11-25
US20020168696A1 (en) 2002-11-14
DE60028040D1 (de) 2006-06-22

Similar Documents

Publication Publication Date Title
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
ATE246361T1 (de) Verfahren zur bestimmung von ige
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE69938623D1 (de) Microarrays und ihre verwendungen
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE69719057D1 (de) Verfahren zur signalverstärkung
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
WO2006113245B1 (en) Methods for measuring glycan levels of proteins
ATE449963T1 (de) Immunoassays unter verwendung von sers (surface enhanced raman scattering)
MXPA06012232A (es) Uso del patron proteogenomico del plasma para diagnostico, clasificacion, prediccion de respuesta a la terapia y comportamiento clinico, estratificacion de la terapia y monitoreo de enfermedad, en malignidades hematologicas.
ATE356832T1 (de) Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2003033731A3 (en) Methods for detecting ovarian cancer
ATE447713T1 (de) S100-proteine und -autoantikörper als serummarker für krebs
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
MXPA03000316A (es) Reactivos y metodos para la identificacion de agentes de enlace.
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
WO2005019831B1 (en) Methods for reducing complexity of a sample using small epitope antibodies
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition